• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声特征、细胞形态学和突变检测对甲状腺恶性及可疑结节细针穿刺细胞学样本诊断准确性的影响:141例患者的前瞻性分析

Impact of ultrasonographic features, cytomorphology and mutational testing on malignant and indeterminate thyroid nodules on diagnostic accuracy of fine needle cytology samples: A prospective analysis of 141 patients.

作者信息

Fulciniti Franco, Cipolletta Campanile Anna, Malzone Maria Gabriella, Chiofalo Maria Grazia, Capiluongo Anna, Monaco Mario, Di Maio Nunzia, Sandomenico Fabio, Botti Gerardo, Chiappetta Gennaro, Vuttariello Emilia, Pezzullo Luciano

机构信息

Clinical Cytopathology Service, Istituto Cantonale di Patologia, Locarno, Switzerland.

Cytohistopathology Laboratory, Istituto Diagnostico Varelli, Naples, Italy.

出版信息

Clin Endocrinol (Oxf). 2019 Dec;91(6):851-859. doi: 10.1111/cen.14089. Epub 2019 Oct 1.

DOI:10.1111/cen.14089
PMID:31483883
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6972562/
Abstract

OBJECTIVE

Fine needle cytology (FNC) is the first-line diagnostic method to determine the benign or malignant nature of thyroid nodules. The gray zone of cytological classifications remains, however, a crucial and challenging area for cytopathologists.

DESIGN, PATIENTS AND MEASUREMENTS: In the present study, 141 thyroid cytological samples, with ultrasonographic suspicious features, have been prospectively analysed. Molecular analyses were performed by an innovative technology using two multiplex PCRs for the amplification of BRAF, N-H-K-RAS and RET exon genes. RNA samples were studied for RET/PTC1 and RET/PTC3 rearrangements by PCR amplification, and the conditions were set-up to study, with a single experiment, both wild-type PAX8 and PAX8/PPARɣ rearrangements. In total, 111 samples were examined for BRAF, N-H-KRAS and RET genes. An ultrasonographic, cytological and molecular correlation was also carried out in an attempt to suggest a possible way to manage the patients with thyroid nodules. Cyto-histological correlation was available in 115 cases, and it was used to verify the global diagnostic accuracy of this combined approach.

RESULTS

According to the histopathological diagnosis, FNC accuracy was 100% for TIR5 and metastases; 89% for TIR4; 84% for TIR3A and 58% for TIR3B. About 11% of the studied samples showed either RET-PTC1 or RET/PTC3 chromosomal rearrangements, and only one sample simultaneously presented RET/PTC1 and RET/PTC3 rearrangements. PAX8/PPARɣ rearrangement was found in 6% of the samples.

CONCLUSIONS

A multidisciplinary approach to the thyroid is therefore necessary to develop innovative methods suitable for an improved diagnostic and prognostic definition of thyroid cancer.

摘要

目的

细针穿刺细胞学检查(FNC)是确定甲状腺结节良恶性的一线诊断方法。然而,细胞学分类的灰色地带仍然是细胞病理学家面临的关键且具有挑战性的领域。

设计、患者与测量:在本研究中,对141份具有超声可疑特征的甲状腺细胞学样本进行了前瞻性分析。采用创新技术进行分子分析,使用两个多重聚合酶链反应(PCR)扩增BRAF、N-H-K-RAS和RET外显子基因。通过PCR扩增研究RNA样本中的RET/PTC1和RET/PTC3重排,并设置条件在单个实验中研究野生型PAX8和PAX8/PPARɣ重排。总共对111份样本进行了BRAF、N-H-KRAS和RET基因检测。还进行了超声、细胞学和分子相关性分析,试图提出一种管理甲状腺结节患者的可能方法。115例病例有细胞组织学相关性,用于验证这种联合方法的整体诊断准确性。

结果

根据组织病理学诊断,FNC对TIR5和转移灶的准确率为100%;对TIR4为89%;对TIR3A为84%,对TIR3B为58%。约11%的研究样本显示RET-PTC1或RET/PTC3染色体重排,只有一个样本同时出现RET/PTC1和RET/PTC3重排。在6%的样本中发现了PAX8/PPARɣ重排。

结论

因此,需要采用多学科方法研究甲状腺,以开发适用于改进甲状腺癌诊断和预后定义的创新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6836/6972562/50fce78bc6a6/CEN-91-851-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6836/6972562/efd5affc22bf/CEN-91-851-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6836/6972562/9e2e0219b2eb/CEN-91-851-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6836/6972562/50fce78bc6a6/CEN-91-851-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6836/6972562/efd5affc22bf/CEN-91-851-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6836/6972562/9e2e0219b2eb/CEN-91-851-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6836/6972562/50fce78bc6a6/CEN-91-851-g003.jpg

相似文献

1
Impact of ultrasonographic features, cytomorphology and mutational testing on malignant and indeterminate thyroid nodules on diagnostic accuracy of fine needle cytology samples: A prospective analysis of 141 patients.超声特征、细胞形态学和突变检测对甲状腺恶性及可疑结节细针穿刺细胞学样本诊断准确性的影响:141例患者的前瞻性分析
Clin Endocrinol (Oxf). 2019 Dec;91(6):851-859. doi: 10.1111/cen.14089. Epub 2019 Oct 1.
2
PREDICTIVE VALUE OF SOMATIC MUTATIONS FOR THE DEVELOPMENT OF MALIGNANCY IN THYROID NODULES BY CYTOPATHOLOGY.甲状腺结节细胞学检查中体突变对恶性肿瘤发展的预测价值。
Endocr Pract. 2016 Sep;22(9):1081-7. doi: 10.4158/EP151057.OR. Epub 2016 May 23.
3
Value of V600E in High-Risk Thyroid Nodules with Benign Cytology Results.V600E 在良性细胞学结果的高危甲状腺结节中的价值。
AJNR Am J Neuroradiol. 2018 Dec;39(12):2360-2365. doi: 10.3174/ajnr.A5898. Epub 2018 Nov 29.
4
Impact of molecular testing in the diagnosis of thyroid fine needle aspiration cytology: data from mainland China.分子检测对甲状腺细针抽吸细胞学诊断的影响:来自中国大陆的数据。
Dis Markers. 2014;2014:912182. doi: 10.1155/2014/912182. Epub 2014 Jan 29.
5
Diagnostic Limitation of Fine-Needle Aspiration (FNA) on Indeterminate Thyroid Nodules Can Be Partially Overcome by Preoperative Molecular Analysis: Assessment of RET/PTC1 Rearrangement in BRAF and RAS Wild-Type Routine Air-Dried FNA Specimens.术前分子分析可部分克服细针穿刺活检(FNA)对甲状腺不确定结节的诊断局限性:BRAF和RAS野生型常规空气干燥FNA标本中RET/PTC1重排的评估
Int J Mol Sci. 2017 Apr 12;18(4):806. doi: 10.3390/ijms18040806.
6
Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany.在德国一家初级转诊机构中,使用七基因检测板对甲状腺细针穿刺进行为期两年的分子检测常规应用评估。
Thyroid. 2017 Mar;27(3):402-411. doi: 10.1089/thy.2016.0445. Epub 2017 Feb 7.
7
RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.不确定甲状腺结节中的RAS突变可预测甲状腺乳头状癌的滤泡变体。
Clin Endocrinol (Oxf). 2015 May;82(5):760-6. doi: 10.1111/cen.12579. Epub 2014 Nov 28.
8
Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.超声/临床特征、细胞学和 BRAF V600E 突变评估在甲状腺结节恶性肿瘤筛查中的作用:一项前瞻性研究。
J Clin Endocrinol Metab. 2012 Jul;97(7):2354-61. doi: 10.1210/jc.2011-3494. Epub 2012 Apr 24.
9
Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study.甲状腺结节细胞学不确定时 7 重基因突变检测的诊断和预后价值:SWEETMAC 研究。
Endocrine. 2021 Feb;71(2):407-417. doi: 10.1007/s12020-020-02411-4. Epub 2020 Jul 7.
10
Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.BRAF(V600E)突变检测与RAS点突变及RET/PTC重排评估在甲状腺癌诊断中的相关性
Thyroid. 2015 Feb;25(2):221-8. doi: 10.1089/thy.2014.0338. Epub 2014 Nov 24.

引用本文的文献

1
Improving the TIR3B oncological stratification: try to bridge the gap through a comprehensive presurgical algorithm.改善 TIR3B 的肿瘤学分层:尝试通过综合术前算法来缩小差距。
J Endocrinol Invest. 2024 Mar;47(3):633-643. doi: 10.1007/s40618-023-02182-5. Epub 2023 Sep 22.
2
The Spectrum of Thyroid Nodules at Kinshasa University Hospital, Democratic Republic of Congo: A Cross-Sectional Study.刚果民主共和国金沙萨大学医院甲状腺结节的分布情况:一项横断面研究。
Int J Environ Res Public Health. 2022 Dec 3;19(23):16203. doi: 10.3390/ijerph192316203.
3
Thyroid Nodules with Indeterminate FNAC According to the Italian Classification System: Prevalence, Rate of Operation, and Impact on Risk of Malignancy. An Updated Systematic Review and Meta-analysis.

本文引用的文献

1
Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.多基因基因组分类器在具有不确定细胞学的甲状腺结节中的表现:一项前瞻性盲法多中心研究。
JAMA Oncol. 2019 Feb 1;5(2):204-212. doi: 10.1001/jamaoncol.2018.4616.
2
Molecular testing in the diagnosis of differentiated thyroid carcinomas.分子检测在分化型甲状腺癌诊断中的应用
Gland Surg. 2018 Aug;7(Suppl 1):S19-S29. doi: 10.21037/gs.2017.11.07.
3
TERT promoter mutational screening as a tool to predict malignant behaviour in follicular thyroid tumours-three examples from the clinical routine.
根据意大利分类系统,甲状腺细针穿刺细胞学检查结果不确定的甲状腺结节:患病率、手术率及对恶性肿瘤风险的影响。一项更新的系统评价和荟萃分析。
Endocr Pathol. 2022 Dec;33(4):457-471. doi: 10.1007/s12022-022-09729-x. Epub 2022 Aug 31.
4
Operation rate and cancer prevalence among thyroid nodules with FNAC report of suspicious for malignancy (TIR4) or malignant (TIR5) according to Italian classification system: a systematic review and meta-analysis.根据意大利分类系统,甲状腺细针穿刺细胞学检查报告为可疑恶性(TIR4)或恶性(TIR5)的甲状腺结节的手术率和癌症患病率:系统评价和荟萃分析。
Endocrine. 2022 Oct;78(1):24-31. doi: 10.1007/s12020-022-03165-x. Epub 2022 Aug 20.
5
Fluorescence Polarization Imaging of Methylene Blue Facilitates Quantitative Detection of Thyroid Cancer in Single Cells.亚甲蓝的荧光偏振成像有助于单细胞甲状腺癌的定量检测。
Cancers (Basel). 2022 Mar 5;14(5):1339. doi: 10.3390/cancers14051339.
6
Application Value of a Deep Convolutional Neural Network Model for Cytological Assessment of Thyroid Nodules.基于深度卷积神经网络模型在甲状腺结节细胞学评估中的应用价值。
J Healthc Eng. 2021 Nov 9;2021:6076135. doi: 10.1155/2021/6076135. eCollection 2021.
7
The Combination of Sonographic Features and the Seven-Gene Panel May be Useful in the Management of Thyroid Nodules With Indeterminate Cytology.超声特征联合七基因panel 检测对于诊断意义不明确的甲状腺结节具有一定的临床应用价值。
Front Endocrinol (Lausanne). 2021 Feb 24;12:613727. doi: 10.3389/fendo.2021.613727. eCollection 2021.
8
Risk of Malignancy (ROM) of Thyroid FNA Diagnosed as Suspicious for Malignancy or Malignant: an Institutional Experience with Systematic Review and Meta-Analysis of Literature.甲状腺细针穿刺诊断为可疑恶性或恶性的肿瘤恶性风险(ROM):系统评价和文献荟萃分析的机构经验。
Endocr Pathol. 2020 Mar;31(1):52-56. doi: 10.1007/s12022-019-09602-4.
TERT 启动子突变筛查作为预测滤泡性甲状腺肿瘤恶性行为的工具——来自临床常规的三个例子。
Virchows Arch. 2018 Nov;473(5):639-643. doi: 10.1007/s00428-018-2386-1. Epub 2018 Jun 2.
4
Rapid methods to create a positive control and identify the rearrangement in FNA thyroid samples by molecular biology.通过分子生物学在细针穿刺甲状腺样本中创建阳性对照并鉴定重排的快速方法。
Oncotarget. 2018 Apr 10;9(27):19255-19262. doi: 10.18632/oncotarget.24995.
5
Molecular testing of BRAF, RAS and TERT on thyroid FNAs with indeterminate cytology improves diagnostic accuracy.对甲状腺细针穿刺活检(FNA)结果为不明确的样本进行BRAF、RAS和端粒酶逆转录酶(TERT)的分子检测可提高诊断准确性。
Cytopathology. 2017 Dec;28(6):482-487. doi: 10.1111/cyt.12493. Epub 2017 Nov 2.
6
Multiplex PCR approach to simultaneously identify several mutations in fine needle cytology thyroid samples.多重聚合酶链反应方法用于同时鉴定细针穿刺甲状腺样本中的多个突变。
Oncotarget. 2017 Jul 25;8(30):49351-49358. doi: 10.18632/oncotarget.17656.
7
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES--2016 UPDATE.美国临床内分泌医师协会、美国内分泌学会及内分泌医师协会甲状腺结节诊断与管理临床实践医学指南——2016年更新版
Endocr Pract. 2016 May;22(5):622-39. doi: 10.4158/EP161208.GL.
8
Thyroid Imaging Reporting and Data System Risk Stratification of Thyroid Nodules: Categorization Based on Solidity and Echogenicity.甲状腺影像报告和数据系统对甲状腺结节的风险分层:基于实性和回声性的分类
Thyroid. 2016 Apr;26(4):562-72. doi: 10.1089/thy.2015.0460. Epub 2016 Feb 9.
9
Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis.除BRAF分析外,基因表达谱在确定甲状腺结节性质不明确中的作用。
Cancer Cytopathol. 2016 May;124(5):340-9. doi: 10.1002/cncy.21681. Epub 2016 Jan 7.
10
Management of Thyroid Nodular Disease: Current Cytopathology Classifications and Genetic Testing.甲状腺结节性疾病的管理:当前的细胞病理学分类与基因检测
Surg Oncol Clin N Am. 2016 Jan;25(1):1-16. doi: 10.1016/j.soc.2015.08.001. Epub 2015 Oct 31.